“Evaluation of Fondaparinux Use on Kidney Function in Hospitalized COVID-19 Patients with Decreased eGFR” (2025) JURNAL FARMASIMED (JFM), 7(2), pp. 359–370. doi:10.35451/jfm.v7i2.2731.